T lymphocyte killing by a xanthine-oxidase-containing immunotoxin

M. G. Battelli, A. Abbondanza, P. L. Tazzari, A. Bolognesi, R. M. Lemoli, F. Stirpe

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We report on the preparation of an immunotoxin consisting of xanthine oxidase, a free-radicalproducing enzyme, covalently linked to an anti-CD3 monoclonal antibody. The immunotoxin retained both enzymic and immunological properties and its toxicity to target cells (a) was greater than that of the free enzyme, (b) was proportional to the enzyme concentration, and (c) was reduced either in the absence of hypoxanthine or by an excess of free anti-CD3 monoclonal antibody. The cytotoxicity and selectivity of the hypoxanthine/conjugated xanthine oxidase system were potentiated by the addition of chelated iron and by washing away the unbound immunotoxin prior to the addition of substrate. The same system was not toxic to bone marrow progenitor cells. A possible use of this immunotoxin for the ex vivo purging of organs to be transplanted from T lymphocytes, to avoid the graft-versus-host reaction, is suggested.

Original languageEnglish
Pages (from-to)421-425
Number of pages5
JournalCancer Immunology, Immunotherapy
Volume35
Issue number6
DOIs
Publication statusPublished - Nov 1992

Fingerprint

Immunotoxins
Xanthine Oxidase
T-Lymphocytes
Enzymes
Monoclonal Antibodies
Hypoxanthine
Poisons
Bone Marrow Cells
Stem Cells
Iron
Transplants

Keywords

  • Anti-CD3 monoclonal antibody
  • Immunotoxin
  • Xanthine oxidase

ASJC Scopus subject areas

  • Oncology
  • Immunology
  • Cancer Research

Cite this

Battelli, M. G., Abbondanza, A., Tazzari, P. L., Bolognesi, A., Lemoli, R. M., & Stirpe, F. (1992). T lymphocyte killing by a xanthine-oxidase-containing immunotoxin. Cancer Immunology, Immunotherapy, 35(6), 421-425. https://doi.org/10.1007/BF01789022

T lymphocyte killing by a xanthine-oxidase-containing immunotoxin. / Battelli, M. G.; Abbondanza, A.; Tazzari, P. L.; Bolognesi, A.; Lemoli, R. M.; Stirpe, F.

In: Cancer Immunology, Immunotherapy, Vol. 35, No. 6, 11.1992, p. 421-425.

Research output: Contribution to journalArticle

Battelli, MG, Abbondanza, A, Tazzari, PL, Bolognesi, A, Lemoli, RM & Stirpe, F 1992, 'T lymphocyte killing by a xanthine-oxidase-containing immunotoxin', Cancer Immunology, Immunotherapy, vol. 35, no. 6, pp. 421-425. https://doi.org/10.1007/BF01789022
Battelli, M. G. ; Abbondanza, A. ; Tazzari, P. L. ; Bolognesi, A. ; Lemoli, R. M. ; Stirpe, F. / T lymphocyte killing by a xanthine-oxidase-containing immunotoxin. In: Cancer Immunology, Immunotherapy. 1992 ; Vol. 35, No. 6. pp. 421-425.
@article{8454bc079b314cb8acbe02f4bdbe4bcb,
title = "T lymphocyte killing by a xanthine-oxidase-containing immunotoxin",
abstract = "We report on the preparation of an immunotoxin consisting of xanthine oxidase, a free-radicalproducing enzyme, covalently linked to an anti-CD3 monoclonal antibody. The immunotoxin retained both enzymic and immunological properties and its toxicity to target cells (a) was greater than that of the free enzyme, (b) was proportional to the enzyme concentration, and (c) was reduced either in the absence of hypoxanthine or by an excess of free anti-CD3 monoclonal antibody. The cytotoxicity and selectivity of the hypoxanthine/conjugated xanthine oxidase system were potentiated by the addition of chelated iron and by washing away the unbound immunotoxin prior to the addition of substrate. The same system was not toxic to bone marrow progenitor cells. A possible use of this immunotoxin for the ex vivo purging of organs to be transplanted from T lymphocytes, to avoid the graft-versus-host reaction, is suggested.",
keywords = "Anti-CD3 monoclonal antibody, Immunotoxin, Xanthine oxidase",
author = "Battelli, {M. G.} and A. Abbondanza and Tazzari, {P. L.} and A. Bolognesi and Lemoli, {R. M.} and F. Stirpe",
year = "1992",
month = "11",
doi = "10.1007/BF01789022",
language = "English",
volume = "35",
pages = "421--425",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "6",

}

TY - JOUR

T1 - T lymphocyte killing by a xanthine-oxidase-containing immunotoxin

AU - Battelli, M. G.

AU - Abbondanza, A.

AU - Tazzari, P. L.

AU - Bolognesi, A.

AU - Lemoli, R. M.

AU - Stirpe, F.

PY - 1992/11

Y1 - 1992/11

N2 - We report on the preparation of an immunotoxin consisting of xanthine oxidase, a free-radicalproducing enzyme, covalently linked to an anti-CD3 monoclonal antibody. The immunotoxin retained both enzymic and immunological properties and its toxicity to target cells (a) was greater than that of the free enzyme, (b) was proportional to the enzyme concentration, and (c) was reduced either in the absence of hypoxanthine or by an excess of free anti-CD3 monoclonal antibody. The cytotoxicity and selectivity of the hypoxanthine/conjugated xanthine oxidase system were potentiated by the addition of chelated iron and by washing away the unbound immunotoxin prior to the addition of substrate. The same system was not toxic to bone marrow progenitor cells. A possible use of this immunotoxin for the ex vivo purging of organs to be transplanted from T lymphocytes, to avoid the graft-versus-host reaction, is suggested.

AB - We report on the preparation of an immunotoxin consisting of xanthine oxidase, a free-radicalproducing enzyme, covalently linked to an anti-CD3 monoclonal antibody. The immunotoxin retained both enzymic and immunological properties and its toxicity to target cells (a) was greater than that of the free enzyme, (b) was proportional to the enzyme concentration, and (c) was reduced either in the absence of hypoxanthine or by an excess of free anti-CD3 monoclonal antibody. The cytotoxicity and selectivity of the hypoxanthine/conjugated xanthine oxidase system were potentiated by the addition of chelated iron and by washing away the unbound immunotoxin prior to the addition of substrate. The same system was not toxic to bone marrow progenitor cells. A possible use of this immunotoxin for the ex vivo purging of organs to be transplanted from T lymphocytes, to avoid the graft-versus-host reaction, is suggested.

KW - Anti-CD3 monoclonal antibody

KW - Immunotoxin

KW - Xanthine oxidase

UR - http://www.scopus.com/inward/record.url?scp=0026656306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026656306&partnerID=8YFLogxK

U2 - 10.1007/BF01789022

DO - 10.1007/BF01789022

M3 - Article

VL - 35

SP - 421

EP - 425

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 6

ER -